Wafra Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-64,313
Closed -$50M 27
2024
Q1
$50M Sell
64,313
-1,728
-3% -$1.23M 2.62% 8
2023
Q4
$38.5M Sell
66,041
-66,183
-50% -$38.6M 2.27% 9
2023
Q3
$71M Hold
132,224
2.37% 9
2023
Q2
$62M Buy
132,224
+56,784
+75% +$23.8M 2.03% 11
2023
Q1
$25.9M Buy
+75,440
New +$25.4M 0.92% 45

Other funds holding LLY

Wafra Inc's LLY Position: Q2 2024 in Review

Wafra Inc sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 64,313 shares — an estimated $50M sold.

Wafra Inc first reported a position in LLY in Q1 2023 and held it in 5 quarters. The position peaked at $71M in Q3 2023. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Wafra Inc reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Wafra Inc sold 64,313 Eli Lilly shares in Q2 2024, an estimated $50M.
  • Wafra Inc first reported a position in Eli Lilly in Q1 2023 and held it in 5 quarters.
  • Wafra Inc's Eli Lilly position peaked at $71M in Q3 2023.
  • 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Wafra Inc's 13F filing for Q2 2024, filed 5 Aug 2024.